Inventor
VAN DE WINKEL JAN G J
NL18 patents
⚠️ This page may combine multiple inventors who share the name “VAN DE WINKEL JAN G J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENMAB AS
11 patentsUS7153507B2Dec 26, 2006
Human antibodies specific for interleukin 15 (IL-15)
GENMAB AS367 citations98
US7595378B2Sep 29, 2009
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
GENMAB AS64 citations97
US7247301B2Jul 24, 2007
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
GENMAB AS215 citations97
US7438907B2Oct 21, 2008
Human monoclonal antibodies against CD25
GENMAB AS50 citations95
US7247304B2Jul 24, 2007
Methods of treating using anti-IL-15 antibodies
GENMAB AS21 citations90
US7329405B2Feb 12, 2008
Human antibodies specific for interleukin 15 (IL-15)
GENMAB AS11 citations83
US9598493B2Mar 21, 2017
Human monoclonal antibodies against CD25
GENMAB AS3 citations72
US7585961B2Sep 8, 2009
Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)
GENMAB AS5 citations72
US7597892B2Oct 6, 2009
Method for treating psoriasis by administering human antibodies specific for Interleukin 15 (IL-15)
GENMAB AS1 citations61
US9458236B2Oct 4, 2016
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
GENMAB AS2 citations60
US10703818B2Jul 7, 2020
Human monoclonal antibodies against CD25
GENMAB AS0 citations51
MEDAREX INC
3 patentsUS6146837ANov 14, 2000
Cyanidin compositions and therapeutic and diagnostic uses therefor
MEDAREX INC38 citations92
US7192582B2Mar 20, 2007
Human monoclonal antibodies to FC alpha receptor (CD89)
MEDAREX INC52 citations91
US6540977B1Apr 1, 2003
Cyanidin compositions and therapeutic and diagnostic uses therefor
MEDAREX INC6 citations73